Innovation Fund News

PyrAmes Inc. announces investment from March of Dimes to support maternal and pediatric health products

PyrAmes Inc. has received an investment from March of Dimes, the leading organization fighting for the health of moms and babies, to support development and commercialization of its wearable technology to noninvasively monitor blood pressure, particularly for new moms and their babies.

 

Innovation Fund February 2023 Impact Report

This Impact Report showcases the progress we’ve made and highlights our roadmap for the future.

 

Raydiant Oximetry Kicks Off Series B Financing Round with an Investment from March of Dimes, February 7, 2023

"As the leading organization fighting to end preventable maternal and infant death and illness, our investment in Raydiant Oximetry furthers our commitment to address the most pressing challenges facing moms and babies,” said Dr. Elizabeth Cherot, Senior Vice President & Chief Medical and Health Officer of March of Dimes

 

March of Dimes launches Innovation Fund as Organization’s Latest Solution to address the Urgent Maternal and Infant HealthCrisis, September 13, 2022

As the leading organization fighting to improve mom and baby health, March of Dimes stays current on the latest scientific breakthroughs and emerging solutions to impact maternal and infant health through earlier diagnosis, new treatments for conditions during and after pregnancy, and ongoing mental and physical health support. With the Innovation Fund, March of Dimes will leverage this expertise to invest in companies with promising solutions to improve health outcomes and impact the lives of moms and babies now.

Watch the Innovation Fund launch event below:

2022 March of Dimes Innovation Fund Launch v2

If you're an early-stage company seeking funding, please submit this initial application form here

If you're interested in learning more about our Innovation Fund, please reach out to Eric Schaefer at [email protected] 

If you're interested in making a philanthropic contribution to our Innovation Fund, please reach out to Karyn DeMartini at [email protected]